IL‐18, a myeloid leukocyte inflammatory mediator, induces IFNγ secretion from T cells and NK cells, and has been shown to confer anti‐tumor activity.[33] One study found an mRNA isoform of another important interleukin, IL‐15, that was preferentially expressed in certain human tumors. This evidence concerns the gene IL18 and neoplasm.